Tag: Merck

Merck

General

HHS: Pharmacists Can Administer COVID-19 Antivirals

HHS: Pharmacists Can Administer COVID-19 Antivirals

Nov. 29, 2021 –With little fanfare, the U.S. Department of Health and Human Services (HHS) recently moved to allow licensed pharmacists to dispense Food and Drug Administration (FDA)-authorized COVID-19 therapeutics directly to patients, without a physician prescription. This step, taken by publishing an amendment to a declaration under the Public Readiness and Emergency Preparedness Act, […]

Read more

DTC Advertising

Several Pharma Companies Join Facebook Ad Boycott

Several Pharma Companies Join Facebook Ad Boycott

July 6, 2020 – Bayer AG, Merck KGaA, Novartis, Pfizer and Vertex are joining other major advertisers in support of a July Facebook ad boycott (#StopHateForProfit), a campaign started by six civil rights organizations – the Anti-Defamation League, NAACP, Sleeping Giants, Color Of Change, Free Press and Common Sense – that calls on corporate advertisers to […]

Read more

DTC Advertising

OPDP Study of Oncology DTC TV Ads Needs Tweaking, Commenters Say

OPDP Study of Oncology DTC TV Ads Needs Tweaking, Commenters Say

Dec. 9, 2019 – The Office of Prescription Drug Promotion’s (OPDP’s) proposed study of  the increasingly-common direct-to-consumer (DTC) television advertising for oncology drugs seeks to examine how consumers parse the information they are receiving, but commenters on the proposal argue that some of the study’s parameters should be changed before moving forward. The proposed OPDP […]

Read more

Courts/First Amendment

Drug Companies Forcefully Counter HHS Appeal on Mandatory Drug Prices in DTC TV Ads

Drug Companies Forcefully Counter HHS Appeal on Mandatory Drug Prices in DTC TV Ads

Nov. 18, 2019 – Amgen, Eli Lilly, Merck & Co. and the Association of National Advertisers (ANA) are once again striking back at the U.S. Department of Health and Human Services (HHS) effort to mandate drug prices in direct-to-consumer (DTC) television ads. Although the four entities sued HHS over its recent regulation calling for the […]

Read more

Courts/First Amendment

Court Rules Mandatory Drug Price Disclosure Rule Invalid, Stating CMS Lacks Statutory Authority

Court Rules Mandatory Drug Price Disclosure Rule Invalid, Stating CMS Lacks Statutory Authority

July 9, 2019 – One day before the Centers for Medicare & Medicaid Services’ (CMS’) final rule requiring drug companies to disclose the wholesale acquisition cost (WAC) or “list price” of their drugs in television ads was due to go into effect, the U.S. District Court for the District of Columbia issued a memorandum opinion […]

Read more

Courts/First Amendment

Three Manufacturers and ANA File Suit against CMS over Drug Price Disclosure Rule

Three Manufacturers and ANA File Suit against CMS over Drug Price Disclosure Rule

June 17, 2019 – The Trump administration’s final rule mandating that drug companies include the wholesale acquisition cost (WAC) in direct-to-consumer (DTC) television ads for many drugs “exceeds [the Department of Health and Human Services’ (HHS’)] statutory authority, violates the First Amendment, and should therefore be set aside,” according to a lawsuit filed Friday, less […]

Read more